As vaccine production falls behind schedule, and the European Union lags in inoculating people, Brussels and London are lobbing threats and accusations at each other.
Tag: Oxford University
India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other
The approvals, which include a shot developed by Bharat Biotech, an Indian pharmaceutical company, begin a vast campaign to inoculate the hard-hit nation’s 1.3 billion people.
U.K. Authorizes Covid-19 Vaccine From Oxford and AstraZeneca
Health officials hope to soon vaccinate up to two million people per week as the country’s hospitals are overwhelmed by cases of a new, more contagious coronavirus variant.
Britain Authorizes Covid-19 Vaccine From Oxford and AstraZeneca
Health officials are hoping to soon vaccinate a million people per week as the country’s hospitals are overwhelmed by cases of a new, more contagious variant of the virus.
How the US, UK and Canada Will Roll Out the Covid Vaccine
Within days, all three countries could be giving the Pfizer-BioNTech vaccine, but they have varying strategies and challenges. The U.S. plan, working through the states, is the least centralized.
Johnson Basks in a Rare Burst of Good U.K. News
The current lockdown is ending and a successful British vaccine could vanquish the virus by spring. But will that be enough to rebuild his sagging political fortunes?
AstraZeneca and Oxford Say Vaccine Is Up to 90 Percent Effective
In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.
Central Europe Suffers as Coronavirus Surges
The Czech Republic, with the highest transmission rate in Europe, closed schools, bars and restaurants. In some countries in Central Europe, there is a critical shortage of doctors and nurses.
Coronavirus Crisis Has Made Brazil an Ideal Vaccine Laboratory
Widespread contagion, a deep bench of scientists and a robust vaccine-making infrastructure have made Brazil an important player in the quest to find a vaccine.
Oxford Covid Vaccine Among Those Developers Say Have Promising Initial Results
Early trials showed a good immune response in vaccinated subjects, but one researcher sounded a note of caution: “There is still a long way to go.”